Key facts
- This page summarizes Armand Girard's Form 4 filing for GLYCOMIMETICS INC (GLYC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Nov 2022, 15:04.
Armand Girard - 11 Nov 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)
- Reporting relationship
- SVP, Chief Business Officer
- Issuer ticker
- GLYC
- Reported as of
- 11 Nov 2022
- Net transaction value
- +$6,825
- SEC form
- 4
- Accepted by SEC
- 14 Nov 2022, 15:04:18 UTC
- Prior SEC filing
- 10 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian F. Leaf, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Armand Girard filed Form 4 for GLYCOMIMETICS INC (GLYC) on 14 Nov 2022.
Change
- Previous filing in this sequence was filed on 10 Mar 2022.
- Current net transaction value: +$6,825.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GLYC
transaction
Common Stock
Purchase
- Transaction value
- $6,825
- Shares
- +6,500
- Change %
- +29%
- Price
- $1.05
- Shares after
- 29,161
- Date
- 11 Nov 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.